Seres Therapeutics, Inc.

NasdaqGS:MCRB Stock Report

Market Cap: US$71.0m

Seres Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MCRB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders54,2670.56%
Institutions982,07910.1%
Public Companies1,089,08811.2%
VC/PE Firms1,155,85011.9%
General Public6,402,65066.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 35.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.9%
Flagship Pioneering, Inc
1,155,850US$8.5m0%0.76%
11.3%
Nestlé S.A.
1,089,088US$8.0m0%no data
3.04%
Vanguard Capital Management, LLC
294,143US$2.2m0%no data
1.44%
Marshall Wace LLP
139,539US$1.0m16.1%no data
1.43%
Vontobel Asset Management, Inc.
138,468US$1.0m34.1%no data
1.09%
Susquehanna International Group, LLP
105,339US$772.1k-41.5%no data
1.05%
BlackRock, Inc.
102,026US$747.9k-1.54%no data
0.77%
Geode Capital Management, LLC
74,835US$548.5k-13.1%no data
0.64%
American Century Investment Management Inc
62,316US$456.8k283%no data
0.41%
Vanguard Fiduciary Trust Company
39,643US$290.6k0%no data
0.35%
State Street Global Advisors, Inc.
33,901US$248.5k0%no data
0.33%
Charles Schwab Investment Management, Inc.
31,630US$231.8k0.83%no data
0.33%
Lion Point Capital, LP
31,570US$231.4k0%0.8%
0.22%
Morgan Stanley
21,700US$159.1k-13.6%no data
0.19%
Two Sigma Investments, LP
18,794US$137.8k-27%no data
0.15%
Northern Trust Global Investments
14,765US$108.2k0%no data
0.15%
Invesco Capital Management LLC
14,547US$106.6k1.3%no data
0.12%
Eric Shaff
12,040US$88.3k4%no data
0.088%
Kelly Brady
8,562US$62.8k1.43%no data
0.088%
Teresa Young
8,557US$62.7k1.86%no data
0.082%
Thomas DesRosier
7,954US$58.3k2.12%no data
0.081%
Matthew Henn
7,838US$57.5k2.1%no data
0.077%
Bridgeway Capital Management, LLC
7,500US$55.0k0%no data
0.073%
UBS Asset Management AG
7,030US$51.5k66.4%no data
0.067%
Barclays Bank PLC
6,507US$47.7k-12.5%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 16:30
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Seres Therapeutics, Inc. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
John NewmanCanaccord Genuity
John TannerCantor Fitzgerald & Co.